Urgent.News

the world's headlines, one feed

Editions

Health & Medicine

An Alzheimer’s Drug Cut Expected Cognitive Decline Roughly in Half. It Didn’t Target Amyloid

Researchers say the oral drug LM11A-31 slowed the decline of brain-network function in a small trial, pointing to a potential broader strategy for treating Alzheimer’s.

An Alzheimer’s Drug Cut Expected Cognitive Decline Roughly in Half. It Didn’t Target Amyloid

We haven't written up this one. Inc. has the full story — the link below goes straight to it.

Read the original at inc.com →

More in Health & Medicine